Sébastien Gillotin —BIO-PROTOCOL

Home About Us For Authors Submit Protocol Archive

Coauthors

François Guillemot The Francis Crick Institute, Mill Hill Laboratory, UK
1 protocol

Coreviewers

Ehsan Kheradpezhouh Australian National University
7 protocols

Emmanuelle Berret Ecole Polytechnique Fédérale de Lausanne
9 protocols

Longping Tse University of North Carolina at Chapel Hill
16 protocols

Oneil Bhalala Baker Institute
44 protocols

Reviewer

Sébastien Gillotin

Post-Doc, The University of Cambridge

Research focus

Neuroscience
Neurogenesis, Transcription, Stem Cells

1 Author merit
Reviewer merit
Editor merit

Education

Ph.D., Imperial College, London, 2007

Publications

https://www.researchgate.net/profile/Sebastien_Gillotin

1 Protocol published

Micro-chromatin Immunoprecipitation (μChIP) Protocol for Real-time PCR Analysis of a Limited Amount of Cells

Authors: Sébastien Gillotin and François Guillemot, date: 06/20/2016, view: 2995, Q&A: 0

Chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) is an important strategy to study gene regulation. When availability of cells is limited, however, it can be useful to focus on specific genes to investigate in depth the role of ...

More >

3 Protocols reviewed

Isolation and Purification of Schwann Cells from Spinal Nerves of Neonatal Rat

Authors: Jinkun Wen, Dandan Tan, Lixia Li and Jiasong Guo, date: 10/20/2017, view: 2507, Q&A: 0

Primary cultured Schwann cells (SCs) are widely used in the investigation of the biology of SC and are important seed cells for neural tissue engineering. Here, we describe a novel protocol for harvesting primary cultured SCs from neonatal ...

More >

A High-throughput Assay for mRNA Silencing in Primary Cortical Neurons in vitro with Oligonucleotide Therapeutics

Authors: Julia F. Alterman, Andrew H. Coles, Lauren M. Hall, Neil Aronin, Anastasia Khvorova and Marie-Cécile Didiot, date: 08/20/2017, view: 2535, Q&A: 0

Primary neurons represent an ideal cellular system for the identification of therapeutic oligonucleotides for the treatment of neurodegenerative diseases. However, due to the sensitive nature of primary cells, the transfection of small interfering ...

More >

More protocols >